臺灣博碩士論文加值系統

本研究主要之目的在定義基因科技產業之產業風險，由於產業風險所涵蓋範圍太廣，故本研究嘗試以三個風險內涵：系統風險、信用風險及成長風險來嘗試解釋產業風險，並測試其對產業風險是否具顯著之解釋能力；而本研究另一個重點則在於探討會計BETA是否可用以替代傳統之系統風險代理變數－即CAPM下之BETA，希望能以會計基本面之變數來建構一評估產業風險的模式。
實證結果顯示，系統風險、信用風險及成長風險確對產業風險有顯著的解釋能力；而以個別會計BETA替代CAPM下之BETA時，模式仍具顯著的解釋能力，然或許因自變數均為會計資訊之本質，雖無複共線性的影響卻仍對迴歸之結果造成干擾，故本研究在最後考慮以線性組合的方式，將所有會計BETA組成變量以代表系統風險，放入模式中測試其對產業風險的解釋能力。結果發現以此會計BETA變量在解釋產業風險的能力上，似乎還更優於CAPM下之BETA，且變數間之干擾不復存在，而能得出一較佳之會計基礎產業風險評量模式。

The main idea of this research is to define the industrial risk of the genetic tech-nology industry. Because the component of the industrial risk is too complicated, this research would like to use three risk profiles: the systematic risk, the credit risk and the growth risk to capture the industrial risk, that isn’t only to realize whether the relation-ship between the industrial risk and its three risk profiles is significant but also to see how the industrial risk can be explained by the three risk profiles. Another issue this re-search would like to know is, if using accounting beta substitutes CAPM’s beta, which is used to be thought a traditional proxy for the systematic risk. This research hope there could be using the accounting–based variables to construct a model to access the indus-trial risk.
The findings indicate that the systematic risk, the credit risk and the growth risk would be significant to the industrial risk, and also have strong ability to explain it. While CAPM’s beta is replaced by individual accounting beta, the regression model is still significant. However, the regression coefficients are changed; there could be a simi-lar nature of our independent variables. So this research makes all accounting beta com-pose a linear function, and puts this new variate into the model and retest. Finally, this research finds that this variate, or can be called”quasi-accounting beta ”, is still signifi-cant to the industrial risk, and the regression coefficients become normal and stable. Furthermore, the ability to explain is much stronger than CAPM’s beta.

中文摘要　．．．．．．．．．．．．．．．．．．．．．． iii
英文摘要　．．．．．．．．．．．．．．．．．．．．．． iv
誌謝辭　　．．．．．．．．．．．．．．．．．．．．．． v
內容目錄　．．．．．．．．．．．．．．．．．．．．．． vi
表目錄　　．．．．．．．．．．．．．．．．．．．．．． viii
圖目錄　　．．．．．．．．．．．．．．．．．．．．．． ix
公式目錄　．．．．．．．．．．．．．．．．．．．．．． x
第一章　　緒論．．．．．．．．．．．．．．．．．．．． 1
　　第一節　　研究背景．．．．．．．．．．．．．．．． 1
　　第二節　　研究動機與目的．．．．．．．．．．．．． 3
　　第三節　　論文架構與研究流程．．．．．．．．．．． 4
第二章　　文獻探討．．．．．．．．．．．．．．．．．． 6
　　第一節　　生物技術．．．．．．．．．．．．．．．． 6
　　第二節　　基因科技．．．．．．．．．．．．．．．． 16
　　第三節　　產業風險．．．．．．．．．．．．．．．． 19
第三章　　研究設計．．．．．．．．．．．．．．．．．． 29
　　第一節　　研究方法．．．．．．．．．．．．．．．． 29
　　第二節　　研究樣本與研究期間．．．．．．．．．．． 29
第三節　　相關變數之衡量．．．．．．．．．．．．． 30
　　第四節　　實證模型與統計方法．．．．．．．．．．． 39
第四章　　實證結果．．．．．．．．．．．．．．．．．． 45
　　第一節　　敘述統計．．．．．．．．．．．．．．．． 45
　　第二節　　Pearson相關分析．．．．．．．．．．．．． 49
　　第三節　　實證結果分析．．．．．．．．．．．．．． 51
第五章 　結論與建議．．．．．．．．．．．．．．．．． 60
　　第一節　　研究結論．．．．．．．．．．．．．．．． 60
　　第二節　　研究限制．．．．．．．．．．．．．．．． 63
　　第三節　　研究建議．．．．．．．．．．．．．．．． 64
參考文獻　　 ．．．．．．．．．．．．．．．．．．．． 65

方文宏(2003)，應用非財務資訊與會計貝他相關研究，中國文化大學會計學研究所未出版之碩士論文。
生物技術開發中心(2000)，生物技術產業年鑑2000，台北：編製者發行。
生物技術開發中心(2003)，2003生技產業白皮書，台北：編製者。
生物技術開發中心(1999)，生物技術工業發展策略，台北：編製者。
田蔚城(1998），生物產業與製藥業-生物產業(上)，台北：九州圖書文物有限公司。
行政院2002年產業科技策略會議(2002, July 2)，行政院科技顧問組，台北。
牟敦剛(1996)，推動我國生物技術及相關產業升級之課題探討，經濟情勢暨評論季刊，2(1)，76-93。
牟敦剛(2003)，生物科技快易通，台北：商周出版。
江晃榮(1996)，生物技術產業現況與市場趨勢，台北：經濟部產業技術資訊服務推廣計畫ITIS。
余朝權(1994)，產業競爭分析專論，臺北：五南出版社。
許美玉(1998)，也為製藥業問診配藥-台灣製藥業的現況與未來，台灣經濟研究月刊，21(11)，100-104。
范文智(1989)，系統風險與財務變數的關係－臺灣股票市場的驗證分析，交通大學管理科學研究所未出版之碩士論文。
徐雪梅(1997)，會計貝他與股票報酬關係之實證研究，東吳大學會計學研究所未出版之碩士論文。
蘇遠志(1995)，八十四年度生物技術領域重要計畫成效研討會評述，生物產業，6(3)，11-19。
蔡新聲(1996)，生物技術與良質米育種及作物資源利用，生物產業，7(2)，1-12。
黃勝忠、蔡奇助(2000)，生物技術在農業生產改進上之應用，生物產業，1(11)，5-10。
孫智麗(2001)，台灣生物技術產業發展現況與策略，臺灣經濟研究月刊，24(12)，74-85。
孫智麗(2003)，台灣生技產業發展現況與產業創新策略，經濟情勢暨評論，9(2)，113-139。
蘇遠志(2000)，生物技術產業國內外市場發展趨勢，生物醫學報導，1，18-36。
郭敏華(2000)，債信評等，臺北：智勝文化。
梁客川(1993)，會計性風險變數與市場風險關聯性之探討-臺灣股票上市公司之實證研究，中山大學企業管理學研究所未出版之碩士論文。
黃旭輝(1992)，臺灣上市公司股票系統風險和會計資訊關聯性之研究，臺灣大學財務金融研究所未出版之碩士論文。
廖國本(1987)，會計資訊應用於臺灣上市股票系統風險預測之研究，交通大學管理科學研究所未出版之碩士論文。
劉世龍(1991)，會計報酬、系統風險與證券定價之關係－臺灣股市之實證，交通大學管理科學研究所未出版之碩士論文。
Altman, E. (1968). Financial ratios, discriminant analysis and the pre-diction of corporate bankruptcy. Journal of Finance, 23(4), 589-609.
Altman, E. (2000). Predicting financial distress of companies: Revis-iting the Z-score and Zeta® models [Online]. Available: http://pages.stern.nyu.edu/~ealtman/papers.html [2000, July]
Altman, E., Haldeman, R., & Narayanan, P. (1977). Zeta analysis: A new model to identify bankruptcy risk of corporations. Journal of Banking & Finance, 1(1), 1-102.
Ball, R., & Brown, P. (1969). Portfolio theory and accounting. Journal of Accounting Research, 7(3), 300-323.
Barad, M., & McDowell, T. (2002). Capturing industry risk in a buildup model [Online]. Available: http://www.ibbotson.com/content/kc_published_research_search.asp?catalog=Article&category=Cost%20of%20Capital&prodID=ARTC82120021 [2002]
Barth, M., Clement, M., Foster, G., & Kasznik, R. (1998). Brand val-ues and capital market valuation. Review of Accounting Studies, 3(1-2). 41-68.
Bartholomew, S. (1997). National systems of biotechnology innova-tion: Complex interdependence in the global system. Journal of International Business Studies, 28(2), 241-266.
Beaver, W., Kettler, P., & Scholes, M. (1970). The association between market determine and accounting determine risk measures. The Accounting Review, 45(3), 654-682.
Beaver, W., & Manegold, J. (1975). The association between mar-ket-determined and accounting-determined measures of system-atic risk: Some further evidence. Journal of Financial and Quantitative Analysis, 10(2), 231-284.
Chung, K. H., & Pruitt, S.W. (1994). A simple approximation of tobin's q. Financial Management, 23(3), 70-74.
Ernst & Young Company. (2003). Global biotechnology Report 2003. New Work: Ernst & Young.
Eskew, R. K. (1979). The forecasting ability of accounting risk meas-ures: Some additional evidence. The Accounting Review, 54(1), 107-118.
Hill, N.C., & Stone, B. K. (1980). Accounting betas, systematic oper-ating risk, and financial leverage: A risk-composition approach to the determinants of systematic risk. Journal of Financial and Quantitative Analysis, 15(3), 595-637.
Hsiao, C. (1986). Analysis of panel data. New York: Cambridge Uni-versity Press.
Lee, C. F., Finnerty, J. E., & Norton, E. A. (1996). Foundations of financial management. New York: McGraw-Hill.
Lee, C. F., Newbold, P., Finnerty, J. E., & Chu, C. C. (1986). On ac-counting-based, market-based and composite-based beta predic-tions: method and implications. The Financial Review, 21(1), 51-68.
Lev, B., & Kunitzky, S. (1974). On the association between smoothing measures and the risk of Common Stocks. The Accounting Re-view, 49(2), 259-270.
Li, R. J. & Henderson, G. V., Jr. (1991). Combined leverage and stock risk. Journal of Financial and Quantitative Analysis, 30(1), 18-39.
Lindenberg, E., & Ross, S. (1981). Tobin’s q ratio and industrial or-ganization. Journal of Business, 54, 1-32
Lintner, J. (1965). The valuation of risk assets and the selection of risky investments in stock portfolios and capital Budgets: A re-ply. Review of Economics and Statistics, 51(2), 222-224.
Mossman, C. E., Bell, G. G., Swartz, L. M., & Turtle, H. (1998). An empirical comparision of bankruptcy models. The Financial Review, 33(2), 35-53.
National Commission on Fraudulent Financial Reporting. (1987). Re-port of the national commission on fraudulent financial report-ing. New York: The committee of sponsoring organizations of the treadway commission.
National Science and Technology Council. (1995). Biotechnology of the 21st century: New horizons. Washington, DC: Executive of-fice of the president of the United States.
Organization for Economic Cooperation and Development. (1993). National innovation systems: A comparative study. Oxford: Oxford university press.
Office of Technology Assessment. (1991). Biotechnology in a global economy. Washington, DC: Congress of United States.
Ohlson, J. A. (1995). Earnings, book value and dividends in equity valuation. Contemporary Accounting Research, 11(2), 661-667.
Roberts, E. B., & Mizouchi, R. (1989). Inter-firm technological col-laboration: The case of Japanese biotechnology. International Journal of Technology Management, 4(1), 43-61.
Ross, S. A., Westerfield, R. W., & Jaffe, J. (1999). Corporate finance. New York: McGraw Hill Companies, Inc.
Sharpe, W. F. (1964). Capitol asset prices: A theory of market equilib-rium under conditions of risk. Journal of Finance, 19(3), 425-442.
Silver, A. D. (1994). The venture capital sourcebook: The definitive guide to finding start-up funds and growth capital. England: Probus Publishing.
Spalding, B. J. (1986). How biotechnology is farming as an industry. Chemical Week, 139(23), 9-13.
Thieman, W. J., Palladino, M. A., & Thieman, W. (2003). Introduction to biotechnology. New York: Benjamin Cummings.
Thompson, D. J. (1976). Sources of systematic risk in common stocks. Journal of Business, 49(2), 173-188.